Evidence map›Paper›PMID 36304523›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2022

Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis.

Sahrish Shah, Meritxell Urtecho, Mohammed Firwana, Tarek Nayfeh, Bashar Hasan, Ahmad Nanaa, Samer Saadi, David N Flynn, Rami Abd-Rabu, Mohamed O Seisa and 5 more

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Sahrish ShahEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Meritxell UrtechoEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Mohammed FirwanaEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Tarek NayfehEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Bashar HasanEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Ahmad NanaaEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Samer SaadiEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
David N FlynnUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
Rami Abd-RabuEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Mohamed O SeisaEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Noora S RajjoubEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Leslie C HassettMayo Clinic Libraries, Mayo Clinic, Rochester, MN.
Alex C SpyropoulosInstitute of Health Systems Science - Feinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, NY, NY.
James D DouketisDepartment of Medicine, McMaster University, Hamilton, Canada.
M Hassan MuradEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN.
Mayo Clinic in Arizona · USMayo Clinic · USMcMaster University · CANorthwell Health · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To summarize the available evidence about the perioperative management of patients who are receiving long-term antiplatelet therapy and require elective surgery/procedures. Methods: This systematic review supports the development of the American College of Chest Physicians guideline on the perioperative management of antiplatelet therapy. A literature search of MEDLINE, EMBASE, Scopus and Cochrane databases was conducted from each database's inception to July 16, 2020. Meta-analyses were conducted when possible. Results: In patients receiving long-term antiplatelet therapy and undergoing elective noncardiac surgery, the available evidence did not show a significant difference in major bleeding between a shorter vs longer antiplatelet interruption, with low certainty of evidence (COE). Compared with patients who received placebo perioperatively, aspirin continuation was associated with increased risk of major bleeding (relative risk [RR], 1.31; 95% CI, 1.15-1.50; high COE) and lower risk of major thromboembolism (RR, 0.74; 95% CI, 0.58-0.94; moderate COE). During antiplatelet interruption, bridging with low-molecular-weight heparin was associated with increased risk of major bleeding compared with no bridging (RR, 1.86; 95% CI, 1.24-2.79; very low COE). Continuation of antiplatelets during minor dental and ophthalmologic procedures was not associated with a statistically significant difference in the risk of major bleeding (very low COE). Conclusion: This systematic review summarizes the current evidence about the perioperative management of antiplatelet therapy and highlights the urgent need for further research, particularly with the increasing prevalence of patients taking 1 or more antiplatelet agents.

Indexed as

ACCP/CHEST, American College of Chest PhysiciansASA, acetylsalicylic acidATE, arterial thromboembolismCABG, coronary artery bypass graftCOE, certainty of evidenceCV, cardiovascularDES, drug-eluting stentLMWH, low-molecular-weight heparinMI, myocardial infarctionPE, pulmonary embolismPICO, patients–interventions–comparators–outcomesPRISMA, Preferred Reporting Items for Systematic Reviews and Meta-AnalysesRCT, randomized clinical trialRR, relative risk

Identifiers

PMID36304523
PMCPMC9594114
OpenAlexW4307059241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.